Floatz logo

.ALPHA.-1 PROTEASE INHIBITOR

Alpha 1-Antitrypsin Deficiency

Grifols Therapeutics LLCprotein_peptidePhase 4 / ApprovedActive
A
81/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
76/ 100
Competitive Position
89/ 100

Competitive context

24 Active assets in the Alpha 1-Antitrypsin Deficiency cohort.

Asset / SponsorPhaseRating
Alpha-1-Proteinase Inhibitor
Grifols Therapeutics LLC
Phase 4A
NORMAL HUMAN SERUM ALBUMIN
Baxalta now part of Shire
Phase 4BBB
.ALPHA.-1 PROTEASE INHIBITOR
Grifols Therapeutics LLC
Phase 3BB
Fazirsiran
Takeda
Phase 3BB
Alpha-1-Proteinase Inhibitor
Grifols Therapeutics LLC
Phase 3BB

View all 50 →

Same molecule, other indications

.ALPHA.-1 PROTEASE INHIBITOR is also rated in:

Chronic Obstructive Pulmonary DiseaseDormant
BBB
Indicative ·
72 / 100
View asset →
alpha 1-antitrypsin deficiencyDormant
BB
Indicative ·
69 / 100
View asset →
Pancreatitis, Chronic; Diabetes; TransplantDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →